Market Overview

Benzinga's Top Downgrades

Share:
Related VVUS
Earnings Scheduled For March 9, 2016
Vivus And Oreixigen Have Too Many Problems For Investors, RBC's Simeonidis Claims
Related CRH
Benzinga's Top Upgrades
Benzinga's Top Upgrades
CRH Medical Announces Date for First Quarter —…–6 Results and Conference Call (GuruFocus)

Jefferies downgraded VIVUS (NASDAQ: VVUS) from “hold” to “underperform.” VIVUS's shares closed at $22.76 yesterday. VIVUS's trailing-twelve-month ROE is -30.47%.

Analysts at Credit Suisse downgraded CRH plc (NYSE: CRH) from “neutral” to “underperform.” CRH's shares closed at $17.87 yesterday. CRH's trailing-twelve-month profit margin is 3.34%.

Analysts at Raymond James downgraded Acme Packet (NASDAQ: APKT) from “market perform” to “underperform.” Acme Packet's shares closed at $17.46 yesterday. Acme Packet's trailing-twelve-month ROA is 4.25%.

RW Baird downgraded MYR Group (NASDAQ: MYRG) from “outperform” to “neutral.” MYR Group's shares closed at $20.41 yesterday. MYR Group's trailing-twelve-month operating margin is 4.31%.

Latest Ratings for VVUS

DateFirmActionFromTo
Feb 2016RBC CapitalDowngradesOutperformSector Perform
Nov 2014Bank of AmericaMaintainsUnderperform
May 2014JP MorganMaintainsNeutral

View More Analyst Ratings for VVUS
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (APKT + CRH)

View Comments and Join the Discussion!